The Pennsylvania Biotechnology Centre (PABC) has announced that Thermo Fisher Scientific has become a founding sponsor supporting the PABC campus in Doylestown, Pa., and their new B+Labs incubator in Philadelphia, US where emerging life science companies can accelerate their journey to commercialization.

Philadelphia recently ranked as one of the top markets in the US for life sciences, with continuous growth and $4 billion in new construction that supports the industry’s expansion.

Through PABC’s existing campus and the new B+Labs incubator, PABC serves a critical need in the region for incubator space that includes the same state-of-the-art technologies that are accelerating drug discovery in other major cities.

As a founding sponsor of B+Labs, which is a partnership between the PABC and Brandywine Realty Trust, Thermo Fisher will provide its advanced technology and expertise to emerging biotech residents.

“With more companies looking to move to Philadelphia and recent growth in the life sciences regionally, there is an urgent need for more support at early stages of development,” said Louis Kassa, CEO of Hepatitis B Foundation, Blumberg Institute, Pennsylvania Biotechnology Centre. “Incubators and accelerators play a significant role in the success of start-ups, and by working with partners such as Thermo Fisher we have the resources to support this success at scale.”